Clorox Q1 net sales down 20% to $1.4B; diluted EPS 17¢ (-75%), adjusted EPS 49¢ (-47%)

CLOROX CO /DE/

2024-Q1 EPS reported $0.17 revenue$1,386,000,000

Net sales $1.4B, down 20%; organic sales down 18%; volume down 26%.
Diluted EPS 17¢ (down 75%); adjusted EPS 49¢ (down 47%); cyberattack caused 15¢ incremental expense.
Gross margin up 240 bps to 38.4% from 36.0% aided by pricing and cost savings.
Net cash from operations $20M, down 89% from $178M; capex $24M vs $46M.
Segments: Health & Wellness -23%, Household -23%, Lifestyle -28%, International -5% (organic +9%).

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.7

CLOROX CO /DE/ reported the first quarter of fiscal year 2024, which ended Sept. 30, 2023 results: revenue $1.4 billion, EPS 17 cents.

Period: the first quarter of fiscal year 2024, which ended Sept. 30, 2023
Revenue: $1.4 billion
EPS: 17 cents
Result: reported results

Exact text from the filing

by the impact of the previously announced cyberattack. All comparisons are with the first quarter of fiscal year 2023 unless otherwise stated. • Net sales decreased 20% to $1.4 billion compared to a 4% net sales decrease in the year-ago quarter. The decrease was driven largely by lower volume resulting from the cyberattack, partially offset by favorable price

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

CLOROX CO /DE/ filing history →

Source: SEC EDGAR

accession 0000021076-23-000046

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.